Terms: = Leukemia AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Diagnosis
39 results:
1. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract] [Full Text] [Related]
2. Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors.
Lv M; Zhai SZ; Wang Y; Xu LP; Zhang XH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Cheng YF; Yan CH; Mo XD; Liu KY; Chang YJ; Huang XJ; Zhao XY
Bone Marrow Transplant; 2019 Aug; 54(8):1287-1294. PubMed ID: 30655602
[TBL] [Abstract] [Full Text] [Related]
3. [Effect of Heterozygosity Loss in HLA Region before Transplantation on HLA Typing in Patients with leukemia].
Zhao JW; Wang JY; Zhang Y; Li QH; Ru K; Wang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):58-64. PubMed ID: 29397819
[TBL] [Abstract] [Full Text] [Related]
4. Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
Maslak PG; Dao T; Bernal Y; Chanel SM; Zhang R; Frattini M; Rosenblat T; Jurcic JG; Brentjens RJ; Arcila ME; Rampal R; Park JH; Douer D; Katz L; Sarlis N; Tallman MS; Scheinberg DA
Blood Adv; 2018 Feb; 2(3):224-234. PubMed ID: 29386195
[TBL] [Abstract] [Full Text] [Related]
5. European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute leukemia Receiving Single Umbilical Cord Blood Transplantation.
Zhu X; Huang L; Zheng C; Tang B; Liu H; Geng L; Tong J; Zhang L; Zhang X; Yao W; Song K; Wang X; Ding K; Sun Z
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2118-2126. PubMed ID: 28807768
[TBL] [Abstract] [Full Text] [Related]
6. Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
Hamdi A; Cao K; Poon LM; Aung F; Kornblau S; Fernandez Vina MA; Champlin RE; Ciurea SO
Bone Marrow Transplant; 2015 Mar; 50(3):411-3. PubMed ID: 25621795
[TBL] [Abstract] [Full Text] [Related]
7. Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.
Morishima Y; Kawase T; Malkki M; Morishima S; Spellman S; Kashiwase K; Kato S; Cesbron A; Tiercy JM; Senitzer D; Velardi A; Petersdorf EW;
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1197-203. PubMed ID: 23747601
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia.
Rodríguez-López R; Donoso M; Fernández-Cavada M; González LM; Margallo A; Corral C; Gallego M; García de Cáceres MT; Herrera T; González C; Vagace JM; Gervasini G
Gene; 2013 Feb; 514(1):31-5. PubMed ID: 23178241
[TBL] [Abstract] [Full Text] [Related]
9. Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy.
Dubois V; Sloan-Béna F; Cesbron A; Hepkema BG; Gagne K; Gimelli S; Heim D; Tichelli A; Delaunay J; Drouet M; Jendly S; Villard J; Tiercy JM
Leukemia; 2012 Sep; 26(9):2079-85. PubMed ID: 22488219
[TBL] [Abstract] [Full Text] [Related]
10. Optimised radiological diagnosis of hepatic fungal infection during the treatment of leukemia.
Petrausch U; Frauenfelder T; Mueller NJ; Arn K; Stussi G; Schanz U
Mycoses; 2012 Sep; 55(5):447-53. PubMed ID: 22320220
[TBL] [Abstract] [Full Text] [Related]
11. KIR molecules: recent patents of interest for the diagnosis and treatment of several autoimmune diseases, chronic inflammation, and B-cell malignancies.
De Re V; Caggiari L; De Zorzi M; Toffoli G
Recent Pat DNA Gene Seq; 2011 Dec; 5(3):169-74. PubMed ID: 21787272
[TBL] [Abstract] [Full Text] [Related]
12. Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.
Lodewyck T; Oudshoorn M; van der Holt B; Petersen E; Spierings E; von dem Borne PA; Schattenberg A; Allebes W; Groenendijk-Sijnke M; Duinhouwer L; Willemze R; Lowenberg B; Verdonck LF; Meijer E; Cornelissen JJ
Leukemia; 2011 Oct; 25(10):1548-54. PubMed ID: 21606965
[TBL] [Abstract] [Full Text] [Related]
13. Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India.
Kumar L; Malik PS; Prakash G; Prabu R; Radhakrishnan V; Katyal S; Hariprasad R
Ann Hematol; 2011 Nov; 90(11):1317-28. PubMed ID: 21409382
[TBL] [Abstract] [Full Text] [Related]
14. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract] [Full Text] [Related]
15. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract] [Full Text] [Related]
16. Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
Petersdorf EW; Anasetti C; Martin PJ; Gooley T; Radich J; Malkki M; Woolfrey A; Smith A; Mickelson E; Hansen JA
Blood; 2004 Nov; 104(9):2976-80. PubMed ID: 15251989
[TBL] [Abstract] [Full Text] [Related]
17. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A
Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966
[TBL] [Abstract] [Full Text] [Related]
18. Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia.
Shibuya A; Kaneko I; Ishii S; Sasaki N
Hematology; 2002 Apr; 7(2):101-3. PubMed ID: 12186699
[TBL] [Abstract] [Full Text] [Related]
19. Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults.
Barker JN; Davies SM; DeFor TE; Burns LJ; McGlave PB; Miller JS; Weisdorf DJ
Br J Haematol; 2002 Jul; 118(1):101-7. PubMed ID: 12100132
[TBL] [Abstract] [Full Text] [Related]
20. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Weisdorf DJ; Anasetti C; Antin JH; Kernan NA; Kollman C; Snyder D; Petersdorf E; Nelson G; McGlave P
Blood; 2002 Mar; 99(6):1971-7. PubMed ID: 11877268
[TBL] [Abstract] [Full Text] [Related]
[Next]
